PeptideStack
5.2kquestions
20kanswers
220users

hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and micronutrient contributions, and the trial incidence data.

50 questions · sorted by votes · page 1 of 3

58 votes 3 answers37k views
Hair started shedding at month three. Does the timing tell me whether it is the drug or the weight loss?

Started tirzepatide in February. Nothing unusual until early June, when the shedding started, and it is now substantial: handfuls in the shower, hair on the pillow,…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
nutrition
nutrition

Eating on a suppressed appetite: hitting nutritional targets inside a small energy budget, micronutrient risk, meal structure, and what the trial…

100 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
protein-intake
protein-intake

Protein targets in grams per kilogram, per-meal distribution and the leucine threshold, and the evidence for a higher intake specifically during…

60 questions
asked by nadia_kowalczyk 20k · 2.0 years ago
41 votes5 answers49k views
What did the placebo arm of STEP 1 report for hair thinning?

The particulars: STEP 1 · hair thinning. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
asked by ines_delacruz 16k · 22 months ago
40 votes3 answers16k views
Would switching agents help the shedding, or is the rate of loss the only variable that matters?

Second wave of shedding, nine months in, and I have been told by two people in strong terms that switching from tirzepatide to semaglutide will fix it because…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
discontinuation
discontinuation

Stopping treatment: tapering versus abrupt cessation, what the trial withdrawal arms measured, clinically driven stops, and the practical planning…

21 questions
asked by siobhan_deasy 9.5k · 12 months ago
38 votes0 answers29k views
What does SURMOUNT-OSA tell me about hair thinning at the 10 mg dose?

For reference: SURMOUNT-OSA · hair thinning · 10 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by petra_hovland 35k · 17 months ago
37 votes5 answers23k views
What does STEP 5 tell me about hair thinning at the 2.4 mg dose?

The particulars: STEP 5 · hair thinning · 2.4 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by coldbox9 41k · 16 months ago
36 votes5 answers69k views
What is the reported incidence of hair thinning on oral semaglutide in PIONEER-1?

Setup, so nobody has to ask: hair thinning · oral semaglutide · PIONEER-1. I have read the primary source rather than the summary, which has left me with more…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
oral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questions
asked by esben_lykke 84k · 2.2 years ago
32 votes 5 answers43k views
What did the placebo arm of SURMOUNT-2 report for hair thinning?

What I have: SURMOUNT-2 · hair thinning. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
asked by esben_lykke 84k · 22 months ago
32 votes 3 answers8.7k views
How do I quantify shedding well enough to know whether it is getting better or worse?

I am four months into a shedding episode and I genuinely cannot tell whether it is slowing down, stable or worse. My perception changes daily and is heavily…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
nutrition
nutrition

Eating on a suppressed appetite: hitting nutritional targets inside a small energy budget, micronutrient risk, meal structure, and what the trial…

100 questions
bloodwork
bloodwork

Laboratory monitoring: which panels are worth ordering, sensible intervals, reference-range versus optimal-range arguments, and how to read a…

296 questions
asked by tare_and_weigh 12k · 6 months ago
30 votes 5 answers45k views
What did the placebo arm of STEP 3 report for hair thinning?

For reference: STEP 3 · hair thinning. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
asked by zainab_mustafa 21k · 2.0 years ago
30 votes0 answers16k views
What is the reported incidence of hair thinning on tirzepatide in SURMOUNT-3?

The case in front of me: hair thinning · tirzepatide · SURMOUNT-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
tirzepatide
tirzepatide

A dual GIP and GLP-1 receptor agonist. Questions here cover the SURPASS and SURMOUNT programmes, the practical differences from a pure GLP-1…

370 questions
asked by rune_thoresen 16k · 11 months ago
29 votes0 answers12k views
Is hair thinning on mazdutide dose-dependent or dose-rate dependent?

Concretely: hair thinning · mazdutide. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me suspicious. My background is…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
mazdutide
mazdutide

A GLP-1 and glucagon receptor dual agonist developed primarily in China, with a distinct dose range and a fast-moving publication record.…

237 questions
asked by Dr_Bram_Verhoeven 84k · 2.0 years ago
27 votes 5 answers21k views
Does holding at 7.5 mg for four weeks before escalating reduce hair thinning?

Concretely: 7.5 mg · four weeks · hair thinning. This is one of those things that everyone repeats and nobody derives. This matters practically, not just…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by stopper_core 28k · 14 months ago
26 votes0 answers13k views
Is hair shedding at month three telogen effluvium or something else?

It has now persisted for three weeks, which is what moved this from tolerable to worth asking about. I can parse the result. I am less sure what it licenses me to…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
nutrition
nutrition

Eating on a suppressed appetite: hitting nutritional targets inside a small energy budget, micronutrient risk, meal structure, and what the trial…

100 questions
protein-intake
protein-intake

Protein targets in grams per kilogram, per-meal distribution and the leucine threshold, and the evidence for a higher intake specifically during…

60 questions
asked by wren_calloway 23k · 16 months ago
26 votes0 answers13k views
What does ATTAIN-1 tell me about hair thinning at the 36 mg dose?

What I have: ATTAIN-1 · hair thinning · 36 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by Dr_Hanne_Solberg 36k · 8 months ago
25 votes 5 answers52k views
When does hair thinning stop being a tolerability issue and become a clinical one?

I am comparing three suppliers on documentation rather than on price. I want to decide this in advance so that I am not deciding it under pressure later. Assume I…

harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

472 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
pancreatitis
pancreatitis

Acute pancreatitis as a labelled risk: background incidence, the signal in pooled trial and pharmacovigilance data, lipase interpretation, and the…

30 questions
asked by hana_petrikova 10k · 2.3 years ago
25 votes 5 answers33k views
What is the reported incidence of hair thinning on semaglutide in FLOW?

Conditions: hair thinning · semaglutide · FLOW. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
asked by mg_per_ml 15k · 2.2 years ago
25 votes 5 answers27k views
What is the reported incidence of hair thinning on semaglutide in STEP 3?

The case in front of me: hair thinning · semaglutide · STEP 3. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
semaglutide
semaglutide

A GLP-1 receptor agonist with a fatty-acid-acylated backbone and a roughly one-week half-life, marketed for type 2 diabetes and for weight…

470 questions
asked by per_haugen 13k · 16 months ago
24 votes 2 answers6.5k views
Does hair thinning at week eight of survodutide usually resolve without a dose change?

What I am working with: hair thinning · eight · survodutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
asked by eoin_mcgarry 18k · 10 months ago
23 votes 5 answers28k views
What is the reported incidence of hair thinning on a GLP-1 receptor agonist in STEP 3?

Setup, so nobody has to ask: hair thinning · a GLP-1 receptor agonist · STEP 3. I would like help reading this properly rather than being told what conclusion to…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
asked by gel_pack_warm 13k · 16 months ago
23 votes 5 answers16k views
What did the placebo arm of ATTAIN-1 report for hair thinning?

Numbers first: ATTAIN-1 · hair thinning. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
asked by fill_volume 22k · 19 months ago
22 votes 3 answers14k views
What does SURPASS-2 tell me about hair thinning at the 15 mg dose?

The specifics, since they change the answer: SURPASS-2 · hair thinning · 15 mg. I want to understand what this actually establishes, as opposed to what it is being…

clinical-trials
clinical-trials

Reading the primary literature properly: estimands, intention-to-treat versus per-protocol, confidence intervals, absolute versus relative…

745 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
asked by kirsi_lahtinen 25k · 5 months ago
21 votes5 answers14k views
Does holding at 7.5 mg for two weeks before escalating reduce hair thinning?

Setup, so nobody has to ask: 7.5 mg · two weeks · hair thinning. I keep seeing this stated as a fact with no explanation attached, and unexplained facts make me…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by retest_please 9.7k · 8 months ago
21 votes0 answers4.8k views
Does hair thinning at week four of survodutide usually resolve without a dose change?

Details up front: hair thinning · four · survodutide. This is a procedural question rather than a theoretical one, and I would like the procedure rather than the…

hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
survodutide
survodutide

A GLP-1 and glucagon receptor dual agonist with a substantial published MASH dataset. Use this tag for its hepatic endpoints, its dose ladder, and…

225 questions
asked by tare_weight 60k · 10 months ago
20 votes 4 answers29k views
Does holding at 0.25 mg for eight weeks before escalating reduce hair thinning?

Setup, so nobody has to ask: 0.25 mg · eight weeks · hair thinning. The empirical answer seems settled. The explanation does not. If the honest answer is that nobody…

titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
hair-loss
hair-loss

Telogen effluvium following rapid weight loss versus a drug-attributable effect: the timing signature that distinguishes them, protein and…

50 questions
dose-escalation
dose-escalation

The decision to move up a step: what evidence supports a four-week interval, what happens when you compress it, and how trial protocols handled…

103 questions
asked by eoin_mcgarry 18k · 15 months ago
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results